Addimmune, Clinical Stage HIV-Focused Gene Therapy Company, To Go Public Through Business Combination With SPAC 10x Capital Venture Acquisition Corp. III
Addimmune, Clinical Stage HIV-Focused Gene Therapy Company, To Go Public Through Business Combination With SPAC 10x Capital Venture Acquisition Corp. III
专注于HIV的临床阶段基因疗法公司Addimmune将通过与SPAC 10x Capital Venture Aquisition Corp. III的业务合并上市
Addimmune, Clinical Stage HIV-Focused Gene Therapy Company, To Go Public Through Business Combination With SPAC 10x Capital Venture Acquisition Corp. III
Addimmune，临床阶段专注于HIV的基因治疗公司，将通过与SPAC 10x Capital Venture收购公司的业务合并上市